Skip to content

Surgery Partners, Inc. SGRY Convertible Preferred Stock Outstanding Shares

Convertible Preferred Stock Outstanding Shares at other companies

UnitedHealth Group logo
UnitedHealth GroupUNH
ARD
Ardent Health PartnersARDT
McKesson logo
McKessonMCK

Other financials

Income statement

See full
Revenue$810.9M+4.5%
Operating income$65.8M+6.3%
Net income-$35.9M+4.8%
EPS (diluted)-$0.28+6.7%

Balance sheet

See full
Cash & equivalents$182.3M-20.5%
Total debt$5.1B+4.6%
Total equity$1.7B-3.0%
Total assets$8.0B+1.2%

Cash flow

See full
Operating cash flow$11.7M+95.0%
CapEx$16.0M-29.5%
Free cash flow-$4.3M+74.3%

Valuation

See full
Market cap$1.99B-49.1%

Profitability

See full
Gross margin23.1%
Operating margin11.8%+1.2pp
Net margin-2.3%-0.9pp
FCF margin6.2%+0.8pp

Returns & leverage

See full
Return on equity-4.4%-1.6pp
Debt / equity+0.2×
Current ratio1.9×0.0×

Where this comes from

Reported directly by Surgery Partners, Inc. in its filing.

Tagged under the XBRL concept us-gaap:PreferredStockSharesOutstanding.

The official record: Surgery Partners, Inc.’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Questions, answered.

What is Surgery Partners, Inc.'s convertible preferred stock outstanding shares?
Surgery Partners, Inc. (SGRY) reported convertible preferred stock outstanding shares of 0 in Q1 2026.
What does convertible preferred stock outstanding shares mean?
This represents the total number of preferred equity shares that carry the right to be converted into common stock. It is a critical indicator of potential future dilution for common shareholders and reflects the company's capital structure strategy regarding hybrid financing instruments.